Immunogenicity 15693
Sample ID
patient2
Response
Positive
Tumor Type
Melanoma
Gene Symbol
DDX3X
Transcript ID
None
HLA INFO
B*56:01
TCR INFO
No TCR info found!
Full length protein sequence (598 aa)
MSHVA
1
VENAL
6
GLDQQ
11
FAGLD
16
LNSSD
21
NQSGG
26
STASK
31
GRYIP
36
PHLRN
41
REATK
46
GFYDK
51
DSSGW
56
SSSKD
61
KDAYS
66
SFGSR
71
SDSRG
76
KSSFF
81
SDRGS
86
GSRGR
91
FDDRG
96
RSDYD
101
GIGSR
106
GDRSG
111
FGKFE
116
RGGNS
121
RWCDK
126
SDEDD
131
WSKPL
136
PPSER
141
LEQEL
146
FSGGN
151
TGINF
156
EKYDD
161
IPVEA
166
TGNNC
171
PPHIE
176
SFSDV
181
EMGEI
186
IMGNI
191
ELTRY
196
TRPTP
201
VQKHA
206
IPIIK
211
EKRDL
216
MACAQ
221
TGSGK
226
TAAFL
231
LPILS
236
QIYSD
241
GPGEA
246
LRAMK
251
ENGRY
256
GRRKQ
261
YPISL
266
VLAPT
271
RELAV
276
QIYEE
281
ARKFS
286
YRSRV
291
RPCVV
296
YGGAD
301
IGQQI
306
RDLER
311
GCHLL
316
VATPG
321
RLVDM
326
MERGK
331
IGLDF
336
CKYLV
341
LDEAD
346
RMLDM
351
GFEPQ
356
IRRIV
361
EQDTM
366
PPKGV
371
RHTMM
376
FSATF
381
PKEIQ
386
MLARD
391
FLDEY
396
IFLAV
401
GRVGS
406
TSENI
411
TQKVV
416
WVEES
421
DKRSF
426
LLDLL
431
NATGK
436
DSLTL
441
VFVET
446
KKGAD
451
SLEDF
456
LYHEG
461
YACTS
466
IHGDR
471
SQRDR
476
EEALH
481
QFRSG
486
KSPIL
491
VATAV
496
AARGL
501
DISNV
506
KHVIN
511
FDLPS
516
DIEEY
521
VHRIG
526
RTGRV
531
GNLGL
536
ATSFF
541
NERNI
546
NITKD
551
LLDLL
556
VEAKQ
561
EVPSW
566
LENMA
571
YEHHY
576
KGSSR
581
GRSKR
586
WLWRL
591
LQQ
596
Mutation Information
DNA mutation:
None
Peptide Range:
385 ~ 393
Mut AA position:
388 (4 in Wild Type peptide)
Alignment
Wild Type:
"FPKEIQMLA
|||.|||||
Mutant:
FPKKIQMLA"
Nature, 2017
An immunogenic personal neoantigen vaccine for patients with melanomaGene Name (from Reference) DDX3X
Checkpoint
Blockade
pembrolizumab
ACT
N
Vaccination
Y
Curative
Effect
tumour regression
minimal_peptide
Y
Antigen
Type
peptide
T-cell
Source
PBMCs
APC
Type
APCs
Assay
None